课题基金 / 基金详情

Medication for childhood ADHD: Adults' outcomes and accounts after long-term treatment.

Medication for childhood ADHD: Adults' outcomes and accounts after long-term treatment.
儿童多动症药物治疗:成人长期治疗后的结果和情况。
批准号:
2399909
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
这个博士项目将评估成人(18岁以上)在儿童时期服用药物治疗ADHD 3年或更长时间的结果。MOCA将是一个混合方法项目,使用定性研究(Strand 1)来检查第一人称账户,进而为流行病学研究提供信息(Strand 2)。这项研究将涉及患有ADHD儿童和成人的父母的PPI。这些人也可能是STRST1研究的参与者。据估计,欧洲有75万儿童和青少年(3-17岁)目前正在服用治疗注意力缺陷多动障碍(ADHD)的药物,其中大多数处方是哌酸甲酯。临床指南建议对严重的儿童ADHD患者进行药物治疗,但疗效的证据主要来自美国的随机对照试验,大多数试验评估了短期内的用药情况,并进行了短期随访。关于成人结果的工作集中于减少ADHD症状和评估公共卫生问题(例如犯罪、药物滥用)。就我们所知,没有人问过患有ADHD的成年人和患有ADHD的儿童的父母,什么结果对他们来说很重要,并测试了ADHD药物是否会改善这些结果。重要的是,那些在儿童时期接受ADHD药物治疗的人的成人结局数据最近才在英国公布,因为ADHD药物只是最近才大量用于儿童,所以长期服用ADHD药物的年轻人队列是新的。研究问题:11)成人ADHD患者如何看待药物治疗,他们的生活受到了哪些方面的影响?2)成人ADHD患者服药后的结果是什么?成年人和父母最感兴趣的是什么?儿童时期长期用药治疗ADHD(>3年)是否继续对成年后(开始服药后5-10年)感兴趣的结局产生影响?方法Strand 1.定性数据将通过焦点小组和对ADHD成年人的半结构化访谈收集,其中一半人服药超过3年,另一半从未服药。将进行一项在线调查,以确定哪些长期结果对ADHD患者最重要。对英国人群代表性队列的分析(英国千年队列研究)将检验ADHD用药数据的趋势,并评估长期用药与Strand 1中确定的成人结局的关联。将利用纵向重复测量混合效应模型对确诊为ADHD和服药3年的ADHD、没有服药的ADHD和没有ADHD的个体的轨迹进行比较。这些分析将使用SDQ多动评分来控制ADHD的严重程度。在不能重复测量结果的情况下,分析将探索那些服用药物的ADHD患者、未服用药物的ADHD患者和没有ADHD的患者之间的结果差异。
英文摘要
This PhD project will assess outcomes for adults (aged 18+ years) who took medication to treat their ADHD for 3 years or more when they were children. MOCA will be a mixed methods project using qualitative research (Strand 1) to examine first person accounts that in turn inform epidemiological research (Strand 2). The research will involve PPI with parents of children with ADHD and adults with ADHD. These individuals may also be participants in the strand 1 studies.An estimated 750,000 children and adolescents (aged 3-17) in Europe are currently taking medication for Attention Deficit Hyperactivity Disorder (ADHD), with most prescribed methylphenidate. Clinical guidelines recommend drug treatment for severe cases of childhood ADHD, but evidence for benefits is largely drawn from randomised controlled trials in the US, most assessing medication use over short periods of time and with short term follow up. Work on adult outcomes has concentrated on reduction in ADHD symptoms and assessing public health concerns (e.g. criminality, substance abuse). To the best of our knowledge nobody has asked adults with ADHD themselves and parents of children with ADHD what outcomes are important to them, and tested whether these are improved by ADHD medication. Importantly, adult outcome data for those who received ADHD medication as children has only recently become available in the UK, as ADHD medication has only been given to children in large numbers relatively recently, so a cohort of young adults who have taken ADHD medication long-term is novel. Research questions:Strand 11) How do adults with ADHD regard medication, and what aspects of their lives have been affected as a result? 2) What adult outcomes after medication for ADHD are of most interest to adults and parents? Strand 23) Does long-term medication for ADHD (>3 years) in childhood continue to have an impact on outcomes of interest (established in strand 1) at adulthood (5-10 years after medication initiation)?MethodsStrand 1. Qualitative data will be collected via focus groups and semi-structured interviews with adults with ADHD, half of whom have taken medication for more than 3 years, and half who have never taken medication. An on-line survey will be conducted to establish which long-term outcomes are most important to people with ADHD. Strand 2. Analysis of a UK population-representative cohort (the UK Millennium Cohort Study) will examine trends in ADHD medication data, and assess the association of long term ADHD medication with adult outcomes identified in strand 1. Comparisons of the trajectories of individuals with diagnosed ADHD and >3 years medication, ADHD with no medication and no ADHD will be conducted utilising longitudinal repeated measures mixed effects modelling. The analyses will be controlling for ADHD severity using Strengths and Difficulties SDQ Hyperactivity scores. Where repeated measures on outcomes are not available, analyses will explore differences in outcomes between those with medicated ADHD, un-medicated ADHD and no ADHD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
  • 批准号:
    32371121
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    孔风
  • 依托单位: